News Related News

Forget Transistors: Data Storage Goes Biological Thanks to Microsoft, University of Washington and Twist Bioscience

Computer giant Microsoft just announced the purchase of 10 million strands of DNA from Twist Bioscience for expanded digital storage research. This follows an initial purchase agreement made in April 2016, and the achievement of a key milestone for the [...]

By | April 17th, 2017|DNA Synthesis, Industry Providers, News|

Twist Bioscience Expands Agreement to Pursue Higher Density Digital Data Storage on DNA with Microsoft and University of Washington

SAN FRANCISCO, Calif. – April 17, 2017 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced Microsoft Corp. will purchase ten million strands of DNA from Twist Bioscience for expanded digital data storage [...]

By | April 17th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Watch Drew Endy’s Keynote at SynBioBeta London 2017

Now available, Drew Endy’s Keynote talk from SynBioBeta London 2017. Interested in more videos like Drew’s? You can watch more of the action from the event if you become a SynBioBeta member. Already a member? Some of the videos have already [...]

By | April 11th, 2017|News|

U.S. EPA awards $300,000 to East Bay small business that harnesses microbes for green chemistry

04/05/2017  - SAN FRANCISCO- The U.S. Environmental Protection Agency awarded $300,000 to Industrial Microbes, Inc., located in Emeryville, Calif., for its innovative work aimed at making chemical manufacturing more efficient and less polluting. The company is one of nine small businesses [...]

By | April 11th, 2017|News, Press Releases|

Codexis Announces Pricing of Public Offering of Common Stock

REDWOOD CITY, Calif., April 07, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a public offering price of $4.00 [...]

By | April 11th, 2017|Chemicals, Energy & Environment, Enzymes, News, Press Releases|

Intellia Therapeutics Announces European Patent Office’s Decision to Grant CRISPR/Cas9 Genome Editing Technology Patent

CAMBRIDGE, Mass., April 11, 2017 (GLOBE NEWSWIRE) -- Intellia Therapeutics (NASDAQ:NTLA), a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR technology, announced that the European Patent Office (EPO) has decided to grant a patent [...]

By | April 11th, 2017|News, Press Releases|